...
首页> 外文期刊>Health policy and planning >Brokering the boundary between science and advocacy: the case of intermittent preventive treatment among infants
【24h】

Brokering the boundary between science and advocacy: the case of intermittent preventive treatment among infants

机译:突破科学与倡导之间的界限:婴儿间歇性预防治疗的情况

获取原文
获取原文并翻译 | 示例

摘要

The process of translating research into policy has gained considerable attention in recent years and a number of studies have investigated the nexus between the two 'worlds' of research and policy. One issue that has been little addressed is about the boundaries between research and advocacy: how far scientists do, or should, promote particular findings to policy makers and others. This article analyses a particular intervention in malaria control and the Consortium set up to accelerate its potential implementation. Using a framework that emphasizes the interplay of interests, institutions and ideas, it provides an example of how a network of committed researchers and funders attempted to follow a rational policy process, but faced conflicts and fundamental questions about their roles in generating scientific evidence and influencing global health policy. In an era of ever more and larger researcher groups and consortia, the findings offer insights and lessons to those engaged in the process of knowledge translation.
机译:近年来,将研究转化为政策的过程受到了相当多的关注,许多研究已经研究了研究和政策这两个“世界”之间的联系。关于研究与倡导之间的界限,一个尚未得到解决的问题是:科学家在多大程度上应该或应该向决策者和其他人推广特定发现。本文分析了对疟疾控制的一种特殊干预措施,该联盟旨在加速其潜在的实施。使用强调利益,机构和思想相互作用的框架,它提供了一个示例,说明了致力于研究人员和资助者的网络如何尝试遵循合理的政策过程,但是在其产生科学证据和影响方面的作用面临冲突和基本问题全球卫生政策。在一个越来越多的研究人员团体和财团的时代,这些发现为从事知识翻译过程的人们提供了见识和教训。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号